Outcomes of “single payer” adoption -
1. All innovation in advancements in treatment of conditions both common and uncommon comes to a screeching halt.
2. “Death panels” which have final authority to choose to suspend or reduce care to palliative treatment only, when the continued life of the patient must show some “economic benefit” measured in “Quality of Life in Remaining Years”, a measurement that may be highly subjective.
3. Delays in the treatment of conditions, leading to deterioration of the condition over time, that change what would have been an easily treated ailment into a life-threatening crisis or even inducing early death.
4. Rules which make it a punishable offense to seek treatment from another unauthorized source, and for which any future participation in any aspect of the single-player scheme is expressly forbidden.
And these are just the more egregious of the bad outcomes of adoption of this system. Longer range, the quality of the medical professionals is sure to decline, as fewer and fewer applicants see much of a future in becoming a medical professional, as the returns on the time invested diminish to the vanishing point, in terms of a sense of dedication, and emotional reward for efforts expended, let alone the economic aspects of a much reduced level of remuneration.
Innovations have stopped now. R&D costs a lot of money, and the finance teams that run publicly traded companies view it was an unnecessary expense.
They keep some around for “Show me”, but not much.